American Century Companies’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-78,882
| Closed | -$13.6M | – | 2413 |
|
|
2021
Q3 | $13.6M | Sell |
78,882
-28,941
| -27% | -$3.79M | 0.01% | 757 |
|
|
2021
Q2 | $13.5M | Buy |
107,823
+5,494
| +5% | +$693K | 0.01% | 756 |
|
|
2021
Q1 | $13.9M | Sell |
102,329
-9,650
| -9% | -$1.25M | 0.01% | 719 |
|
|
2020
Q4 | $14.3M | Sell |
111,979
-5,888
| -5% | -$690K | 0.01% | 692 |
|
|
2020
Q3 | $13.3M | Buy |
117,867
+1,217
| +1% | +$121K | 0.01% | 642 |
|
|
2020
Q2 | $11.1M | Sell |
116,650
-33,814
| -22% | -$3.26M | 0.01% | 647 |
|
|
2020
Q1 | $13.5M | Sell |
150,464
-48,209
| -24% | -$3.75M | 0.02% | 530 |
|
|
2019
Q4 | $10.5M | Buy |
198,673
+72,842
| +58% | +$3.32M | 0.01% | 671 |
|
|
2019
Q3 | $4.97M | Buy |
125,831
+7,484
| +6% | +$325K | 0.01% | 797 |
|
|
2019
Q2 | $4.86M | Buy |
118,347
+24,071
| +26% | +$997K | ﹤0.01% | 844 |
|
|
2019
Q1 | $4.39M | Sell |
94,276
-29,090
| -24% | -$1.28M | ﹤0.01% | 846 |
|
|
2018
Q4 | $5.37M | Sell |
123,366
-26,251
| -18% | -$1.31M | 0.01% | 785 |
|
|
2018
Q3 | $8.56M | Sell |
149,617
-3,941
| -3% | -$194K | 0.01% | 698 |
|
|
2018
Q2 | $7.45M | Buy |
153,558
+27,461
| +22% | +$1M | 0.01% | 736 |
|
|
2018
Q1 | $4.93M | Sell |
126,097
-87,290
| -41% | -$3.71M | 0.01% | 836 |
|
|
2017
Q4 | $9.06M | Buy |
213,387
+181,423
| +568% | +$6.8M | 0.01% | 672 |
|
|
2017
Q3 | $1.19M | Buy |
+31,964
| New | +$1.11M | ﹤0.01% | 1115 |
|
|
2017
Q1 | – | Sell |
-31,768
| Closed | -$811K | – | 1411 |
|
|
2016
Q4 | $811K | Sell |
31,768
-1,163
| -4% | -$36.8K | ﹤0.01% | 1166 |
|
|
2016
Q3 | $1.19M | Sell |
32,931
-81
| -0.2% | -$2.68K | ﹤0.01% | 1137 |
|
|
2016
Q2 | $1.12M | Sell |
33,012
-1,105
| -3% | -$35.9K | ﹤0.01% | 1121 |
|
|
2016
Q1 | $900K | Sell |
34,117
-2,757
| -7% | -$80.2K | ﹤0.01% | 1119 |
|
|
2015
Q4 | $1.8M | Sell |
36,874
-107
| -0.3% | -$3.85K | ﹤0.01% | 1038 |
|
|
2015
Q3 | $921K | Buy |
36,981
+12,698
| +52% | +$382K | ﹤0.01% | 1132 |
|
|
2015
Q2 | $768K | Buy |
24,283
+14,562
| +150% | +$470K | ﹤0.01% | 1178 |
|
|
2015
Q1 | $370K | Hold |
9,721
| – | – | ﹤0.01% | 1282 |
|
|
2014
Q4 | $379K | Buy |
9,721
+1,290
| +15% | +$45K | ﹤0.01% | 1326 |
|
|
2014
Q3 | $255K | Buy |
+8,431
| New | +$238K | ﹤0.01% | 1360 |
|
American Century Companies's XLRN Position: Q4 2021 in Review
American Century Companies sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 78,882 shares — an estimated $13.6M sold.
American Century Companies first reported a position in XLRN in Q3 2014 and held it in 27 quarters. The position peaked at $14.3M in Q4 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- American Century Companies reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- American Century Companies sold 78,882 Acceleron Pharma shares in Q4 2021, an estimated $13.6M.
- American Century Companies first reported a position in Acceleron Pharma in Q3 2014 and held it in 27 quarters.
- American Century Companies's Acceleron Pharma position peaked at $14.3M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on American Century Companies's 13F filing for Q4 2021, filed 7 Feb 2022.